ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026
Long-term Mortality Trends Among Individuals With Tuberculosis: A Retrospective Cohort Study of Individuals Diagnosed With Tuberculosis in Brazil.
Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- The Impact of Directly Observed Therapy on Successful Tuberculosis Treatment: A Statistical Analysis of National Notifications Data.Open forum infectious diseases · 2026Article
- Long-term risk of death after tuberculosis diagnosis and treatment.Nature medicine · 2026Article
- Multidimensional assessment of structural post-tuberculosis lung sequelae and respiratory health status in adults from northern Peru.Frontiers in medicine · 2026Article
- Post-tuberculosis lung disease: a joint effort to provide better management in Europe and Brazil.Respiratory research & clinical practice · 2026Article
- Lipidomics-Based Identification of Plasma Lipid Biomarkers in Tuberculosis-Coronary Artery Disease Comorbidity.Infection and drug resistance · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundEven after successful treatment, individuals surviving tuberculosis (TB) disease experience elevated mortality rates. However, there is limited evidence on how these risks vary over time and by individual characteristics.
methodsWe conducted a retrospective cohort study of individuals diagnosed with TB in Brazil, using national TB notifications and linked mortality records for 2007-2016. We estimated mortality rate ratios (MRRs) and cumulative mortality by year since TB diagnosis, compared to general population mortality matched on age, sex, year, and state. We identified clinical and sociodemographic factors associated with elevated post-TB mortality, and compared the distribution of causes of death to the general population.
resultsThe study sample included 834 594 individuals, with 4.1 million person-years of follow-up (average, 4.9 years). The TB cohort had elevated mortality compared to the general population, particularly in the first year postdiagnosis (MRR, 11.28 [95% confidence interval {CI}, 11.18-11.37]). Post-TB MRRs declined from 3.59 (95% CI, 3.53-3.64) in year 2 to 1.46 (95% CI, 1.34-1.59) in year 10. Cumulative excess mortality was 6.12% (95% CI, 6.07%-6.17%) after 1 year and 9.90% (95% CI, 9.58%-10.24%) after 10 years. MRRs were highest for individuals 30-44 years old at diagnosis. Relapse, loss to follow-up, and co-prevalent conditions like human immunodeficiency virus (HIV) and alcohol use disorder were strongly associated with higher MRRs. Over time, major causes of death in the TB cohort shifted from TB and HIV to cardiovascular disease, cancer, and non-TB respiratory diseases.
conclusionsIndividuals developing TB disease face elevated mortality up to 10 years after diagnosis. These excess risks vary across demographic and clinical characteristics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.